You are unique
Just like your path to healing
So let's Pre-Cure

Despite each patient having a unique cancer profile, treatment selection relies on general criteria (one-size-fits-all).

It is estimated that cancer drugs are generally ineffective in a ~ 75% of patients.

Targeted therapies, based on molecular profiling, can benefit less than 10% of patients.

In vitro models based on tissue specimens or organoids fail to accurately replicate the dynamic physiological microenvironment, crucial for the successful prediction of treatment outcomes.

Pre-Cure transforms cancer treatment selection powered by advanced customized microfluidic tumor-on-a-chip technology.

In Pre-cure organ-on-a-chip becomes patient-on-a-chip where the entire clinical journey is reflected to provide accurate individual therapy predictions.

Find out more

Contact us

Contact us, and we will get back to you as soon as possible.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.